Gain Therapeutics (GANX) Earnings Prediction
Updated August 11, 2026 · AltIndex alt-data view going into the print
AltIndex AI Score on Gain Therapeutics is 50 — signals are mixed heading into the print. Underlying trend: 2 of 4 tracked signals trending down over the last 3 months.
GANX stock price — last 3 months
Gain Therapeutics (GANX) is trading at $1.77, down 0.6% over the last 3 months (from $1.78 three months ago).
What the alt-data signals say about Gain Therapeutics right now
Trends across the last 3 months — the run-up to Gain Therapeutics’s next earnings print.
| Signal | Current | 3-month change |
|---|---|---|
| Job postings | 0 | No 3-month baseline |
| LinkedIn headcount | 25 | ↓ -10.7% |
| Sentiment | 30% Bearish | ↓ -33pp |
| Web traffic | 14,619 | ↑ +13.4% |
| Employee business outlook | 0% Negative | → flat |
Full daily-resolution trend charts on every signal are on the GANX ticker page.
Get alerted when GANX signals inflect
AltIndex stock alerts fire when alt-data on GANX breaks out — web traffic spike, hiring surge, sentiment shift — often days before the earnings number confirms it.
Sign up to AltIndex →Gain Therapeutics earnings: frequently asked questions
When does Gain Therapeutics report earnings next?
What does the AltIndex AI Score say about Gain Therapeutics going into earnings?
What is the EPS estimate for Gain Therapeutics?
How accurate are AltIndex’s earnings predictions for Gain Therapeutics?
Where can I see the full signal breakdown on Gain Therapeutics?
How can I get alerted before Gain Therapeutics reports earnings?
Other earnings predictions
Other companies in the AltIndex universe reporting earnings in the next 2 weeks, sorted by AI Score.
See every alt-data signal on GANX
Sign up to see the full daily-resolution trend charts on every signal AltIndex tracks for Gain Therapeutics — web traffic, hiring, 8-platform social audience, sentiment, insider trades and the full AI Score breakdown.
Sign up to AltIndex → Log inAbout AltIndex
